Clinical Trials Exploring Bevacizumab in NSCLC

Clinical Trials Exploring Bevacizumab in NSCLC

Targeted Oncology

54 года назад

338 Просмотров

Catherine Shu, MD, medical oncologist, Division of Hematology/Oncology, Columbia University Medical Center, discusses two clinical trials exploring the use of bevacizumab (Avastin) in patients with non–small cell lung cancer (NSCLC).

Тэги:

#targeted_oncology #oncology #cancer
Ссылки и html тэги не поддерживаются


Комментарии: